Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on osteoporosis from the 2014 Santa Fe Bone symposium.
Lewiecki EM, Bilezikian JP, Binkley N, Hans D, Krueger D, Miller PD, Oates M, Shane E. Lewiecki EM, et al. Among authors: oates m. Endocr Res. 2015;40(2):106-19. doi: 10.3109/07435800.2015.1005746. Epub 2015 Mar 24. Endocr Res. 2015. PMID: 25803304
The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study.
Geusens P, Oates M, Miyauchi A, Adachi JD, Lazaretti-Castro M, Ebeling PR, Perez Niño CA, Milmont CE, Grauer A, Libanati C. Geusens P, et al. Among authors: oates m. JBMR Plus. 2019 Aug 2;3(10):e10211. doi: 10.1002/jbm4.10211. eCollection 2019 Oct. JBMR Plus. 2019. PMID: 31687647 Free PMC article.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C. Brown JP, et al. Among authors: oates mk. J Bone Miner Res. 2021 Nov;36(11):2139-2152. doi: 10.1002/jbmr.4409. Epub 2021 Aug 10. J Bone Miner Res. 2021. PMID: 34190361 Free PMC article. Clinical Trial.
Skeletal responses to romosozumab after 12 months of denosumab.
McClung MR, Bolognese MA, Brown JP, Reginster JY, Langdahl BL, Shi Y, Timoshanko J, Libanati C, Chines A, Oates MK. McClung MR, et al. JBMR Plus. 2021 Jun 3;5(7):e10512. doi: 10.1002/jbm4.10512. eCollection 2021 Jul. JBMR Plus. 2021. PMID: 34258507 Free PMC article.
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE, Libanati C, Ferrari S. Cosman F, et al. Among authors: oates mk. Osteoporos Int. 2022 Jun;33(6):1243-1256. doi: 10.1007/s00198-021-06174-0. Epub 2022 Feb 15. Osteoporos Int. 2022. PMID: 35165774 Free PMC article.
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Miller PD, et al. Among authors: oates m. J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20. J Bone Miner Res. 2022. PMID: 35466448 Free PMC article. Clinical Trial.
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Langdahl B, Hofbauer LC, Ferrari S, Wang Z, Fahrleitner-Pammer A, Gielen E, Lakatos P, Czerwinski E, Gimeno EJ, Timoshanko J, Oates M, Libanati C. Langdahl B, et al. Among authors: oates m. Osteoporos Int. 2022 Dec;33(12):2527-2536. doi: 10.1007/s00198-022-06544-2. Epub 2022 Sep 29. Osteoporos Int. 2022. PMID: 36173415 Free PMC article. Clinical Trial.
221 results